Echogenesis Therapeutics Inc.
Pittsburgh, PA
- UEI
- NZCGRHMV5ZQ4
- CAGE
- Not on record
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 5403 Friendship Ave, Pittsburgh, PA 15232, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Cell type-specific gene therapy approach for tomt-linked congenital hearing loss - project summary/abstract hearing loss… | National Institute on Deafness and Other Communincation Disorders | $611,256 |
Quick answers
What is Echogenesis Therapeutics Inc.'s UEI?
Echogenesis Therapeutics Inc.'s Unique Entity ID (UEI) in SAM.gov is NZCGRHMV5ZQ4.
Where is Echogenesis Therapeutics Inc. located?
Echogenesis Therapeutics Inc.'s physical address in SAM.gov is 5403 Friendship Ave, Pittsburgh, PA 15232, USA.
Is Echogenesis Therapeutics Inc. registered in SAM.gov?
Yes. Echogenesis Therapeutics Inc.'s SAM.gov registration is active through December 22, 2026.
What is Echogenesis Therapeutics Inc.'s most recent federal award?
Echogenesis Therapeutics Inc.'s most recent federal grant award is Cell type-specific gene therapy approach for tomt-linked congenital hearing loss - project summary/abstract hearing loss… (R41DC022471), from National Institute on Deafness and Other Communincation Disorders, on January 6, 2025.
On GovTribe
See Echogenesis Therapeutics Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors